EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access

Intravenous Laser Therapy in Patients With Acute Kidney Injury: A Randomized Clinical Trial

Mohammad Reza Razzaghi iD, Esmat Ghanei iD, Sheida Malekian iD, Mohammad Mohsen Mazloomfard iD

Journal of Lasers in Medical Sciences · 19.09.2021 · 12 (1) · e49-e49

DOI: 10.34172/jlms.2021.49 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Lasers in Medical Sciences, online erschienen am 19.09.2021. Verfasst von Mohammad Reza Razzaghi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Laser Application in Medical Sciences Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Although intravascular laser irradiation of blood (ILIB) is deemed an innocuous and useful technique for laser therapy, particularly when systemic effects are required, no study, to our knowledge, has been conducted on the effectiveness and innocuousness of ILIB in treating acute kidney injury (AKI).

Objective

This study aimed to assess the feasibility and outcomes of ILIB in the management of patients with AKI and comparing them with the Sham-laser group. Materials and Methods: Twenty-six patients with intra-renal AKI (24-95 years old) at Tajrish Hospitals were evaluated for enrollment eligibility in this clinical trial study. This study was conducted at the nephrology department of Shahid Beheshti University of Medical Science, Tehran, Iran, between 2018 and 2019. Based on the treatment method, the patients’ assignment to two groups (ILIB or Sham-laser) was randomly done. Demographic characteristics, need for dialysis, hemoglobin and serum biochemistry changes, serum and urine neutrophil gelatinase-associated lipocalin (NGAL) changes, laser complications, and the hospitalization period were recorded.

Results

In terms of the baseline characteristics and biochemistry serum level, no differences were seen between the two groups. All post-treatment parameters, except the hemoglobin value, significantly improved in both groups. Urine NGAL and serum NGAL show declines from the baseline in both groups; however, the reduction slope of these parameters occurred faster in the laser group in a statistically significant manner.

Conclusion

A decline in NGAL levels in the laser group during the treatment may suggest that the ILIB can help patients with AKI recover better.

Schlagwörter

Stichwörter der Autor:innen

Acute kidney injuryAcute renal failureBiomarkerLaserNeutrophil gelatinase-associated lipocalin

Autor:innen und Institutionen

  • Laser Application in Medical Sciences Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Department of Internal Medicine, Shohada-e-Tajrish Hospital, Tajrish Sq, Tehran, Iran.

ORCID-Profile: Mohammad Reza Razzaghi, Esmat Ghanei, Sheida Malekian, Mohammad Mohsen Mazloomfard

Zitieren

APA

Razzaghi, M. R., Ghanei, E., Malekian, S., & Mazloomfard, M. M. (2021). Intravenous Laser Therapy in Patients With Acute Kidney Injury: A Randomized Clinical Trial. Journal of Lasers in Medical Sciences, 12(1), e49-e49. https://doi.org/10.34172/jlms.2021.49

Vancouver

Razzaghi MR, Ghanei E, Malekian S, Mazloomfard MM. Intravenous Laser Therapy in Patients With Acute Kidney Injury: A Randomized Clinical Trial. Journal of Lasers in Medical Sciences. 2021;12(1):e49-e49. doi:10.34172/jlms.2021.49

BibTeX
@article{Razzaghi2021,
  author = {Razzaghi, Mohammad Reza and Ghanei, Esmat and Malekian, Sheida and Mazloomfard, Mohammad Mohsen},
  title = {Intravenous Laser Therapy in Patients With Acute Kidney Injury: A Randomized Clinical Trial},
  journal = {Journal of Lasers in Medical Sciences},
  year = {2021},
  volume = {12},
  number = {1},
  pages = {e49--e49},
  doi = {10.34172/jlms.2021.49}
}
Kostenlos starten →